Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211534 · ClinicalTrials.gov registry record · NA
Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty
A NA study of Post-Operative Pain Following Total Knee Arthroplasty, sponsored by Regenesis Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 14
- Study locations
NCT02211534 is a NA study of Post-Operative Pain Following Total Knee Arthroplasty that has completed, run by Regenesis Biomedical. The registered enrollment target is 35 participants. The trial reports 14 study locations across 12 states.
The verdict
NCT02211534, a NA study of Post-Operative Pain Following Total Knee Arthroplasty, has completed, sponsored by Regenesis Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to investigate whether pulsed electromagnetic energy field (PEMF) therapy is effective in the treatment of persistent pain following total knee arthroplasty (TKA)
Conditions Studied
Interventions
- DEVICE Pulsed Electromagnetic Field Device (Provant)
- DEVICE Sham Pulsed Electromagnetic Field Device
Study Locations (14)
Arizona
- - Phoenix
- - Phoenix
Florida
- - Bradenton
- - Fort Lauderdale
Alabama
- - Birmingham
California
- - El Cajon
Colorado
- - Lone Tree
Nevada
- - Las Vegas
New York
- - New York
North Carolina
- - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02211534
The ClinicalTrials.gov registry entry for NCT02211534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenesis Biomedical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-Operative Pain Following Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Pulsed Electromagnetic Field Device (Provant) is the first listed.
NCT02211534 reports 14 study locations spanning 12 distinct geographic areas - top geographies include Arizona, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT02211534 about?
NCT02211534 is a clinical study titled "Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty". The purpose of this study is to investigate whether pulsed electromagnetic energy field (PEMF) therapy is effective in the treatment of persistent pain following total knee arthroplasty (TKA)
What is the current status of trial NCT02211534?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-09. Estimated completion is 2016-03.
What conditions does trial NCT02211534 study?
This clinical trial studies the following conditions: Post-Operative Pain Following Total Knee Arthroplasty.
What interventions are being tested in trial NCT02211534?
The interventions under investigation include: Pulsed Electromagnetic Field Device (Provant) (DEVICE), Sham Pulsed Electromagnetic Field Device (DEVICE).
Who is sponsoring clinical trial NCT02211534?
This trial is sponsored by Regenesis Biomedical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02211534 being conducted?
This trial has 14 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.